Cargando…
Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory’s Retrospective Experience
Prenatal cell-free DNA screening (cfDNA) can identify fetal chromosome abnormalities beyond common trisomies. Emanuel syndrome (ES), caused by an unbalanced translocation between chromosomes 11 and 22, has lacked a reliable prenatal screening option for families with a carrier parent. A cohort of ca...
Autores principales: | Soster, Erica, Dyr, Brittany, Caldwell, Samantha, Sussman, Amanda, Magharyous, Hany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606745/ https://www.ncbi.nlm.nih.gov/pubmed/37895273 http://dx.doi.org/10.3390/genes14101924 |
Ejemplares similares
-
Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations
por: Soster, Erica, et al.
Publicado: (2023) -
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
por: Soster, Erica, et al.
Publicado: (2021) -
Derivative 11;22 (Emanuel) Syndrome: A Case Report and A Review
por: Choudhary, Madan Gopal, et al.
Publicado: (2013) -
Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
por: Soster, Erica, et al.
Publicado: (2023) -
Non-invasive prenatal screening for Emanuel syndrome
por: Luo, Yuqin, et al.
Publicado: (2020)